IceCure Medical Ltd (ICCM)
$1.10+1.85%Close
SELLCRISIS · day 44
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 0.43
- P/E (TTM)
- -0.16
- Short % float
- 3.01%
- Days to cover
- 1.0
- SI change
- -49.2%
- 1W
- -13.39%
- 1M
- -47.37%
- vs SPY 1W
- -13.25%
- vs SPY 1M
- -49.87%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 12
- VALUE
- 20
- GROWTH
- 32
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-104.6%
REV YoY-
ROE-174.3%
EPS YoY-
ROA-95.3%
GROSS36
OP-556
NET-428
[VALUATION]
P/E TTM-0.16
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B0.29
P/FCF-
EV/EBITDA0.58
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.76
ALTMAN Z-
CURR RATIO2.87
ND/EBITDA-
BETA0.43
Company news
FAQ
- What is LOPJLB’s current signal on ICCM?
- LOPJLB’s latest quantitative signal on IceCure Medical Ltd (ICCM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ICCM in?
- IceCure Medical Ltd (ICCM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does IceCure Medical Ltd (ICCM) do?
- Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.